Business
Cryoport to Report Second Quarter 2019 Financial Results on August 8th, 2019
IRVINE, Calif., July 25, 2019 /PRNewswire/ -- Cryoport, Inc. (NASDAQ: CYRX) (NASDAQ: CYRXW) ("Cryoport" or "the Company"), the world's leading
About this update from Cryoport, Inc.
[{"type":"text","content":"IRVINE, Calif., July 25, 2019 /PRNewswire/ -- Cryoport, Inc. (NASDAQ: CYRX) (NASDAQ: CYRXW) (\"Cryoport\" or \"the Company\"), the world's leading temperature-controlled logistics company dedicated to the life sciences industry, today announced that the Company will report financial results for the second quarter ended June 30, 2019 on Thursday, August 8, 2019 after U.S. markets close. \n\n \nIn addition to the earnings release, a document titled \"Cryoport Second Quarter 2019 in Review\", which will provide a review of Cryoport's recent financial and operational performance and a general business update, will be issued by management at 4:05 pm ET on Thursday, August 8. The document is designed to be read by investors before the questions and answers conference call and can be accessed at http://ir.cryoport.com/events-and-presentations. \nCryoport management will host a conference call at 5:00 pm ET on August 8, 2019. The conference call will be in the format of a questions and answers session and will address any queries investors have regarding the Company's reported results. \nConference Call Information\nAn archive of the question and answer webcast will be available approximately three hours after completion of the live event and will be accessible on the Investor Relations section of the Company's website at www.cryoport.com for a limited time. To access the replay of the webcast, please follow this link. A dial-in replay of the call will also be available to those interested until August 15, 2019. To access the replay, dial +1 (844) 512-2921 (United States) or +1 (412) 317-6671 (International) and enter replay pin number: 10007349. \nAbout Cryoport, Inc.Cryoport is the life sciences industry's most trusted global provider of temperature-controlled logistics solutions for temperature-sensitive life sciences commodities, serving the biopharmaceutical market with leading-edge logistics solutions for biologic materials, such as regenerative medicine, including immunotherapies, stem cells and CAR T-cells. Cryoport also provides a range of bioservices to the life sciences industry, including biostorage for biological specimens, materials and samples. Cryoport's solutions are used by points-of-care, CRO's, central laboratories, pharmaceutical companies, manufacturers, university researchers et al; as well as the reproductive med...